Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda M Lulu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annual Review of Medicine|January 27, 2026
CAR T Cell Toxicities and Emerging Treatment StrategiesAmanda M Lulu, Erica Steele, Daniel W Lee
Molecular Cancer Therapeutics|March 7, 2026
αvβ3 CAR-T Cells Simultaneously Targeting Tumor and Metastases Produce Highly Effective Control in Preclinical Models of Melanoma and Triple-Negative Breast CancerDustin A Cobb, Philip Mollica, Lixia Liu, et al.
Cancer Immunology Research|August 20, 2021
Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer PatientsAmanda M Lulu, Kara L Cummings, Erin D Jeffery, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annual Review of Medicine|January 27, 2026
CAR T Cell Toxicities and Emerging Treatment StrategiesAmanda M Lulu, Erica Steele, Daniel W Lee
Molecular Cancer Therapeutics|March 7, 2026
αvβ3 CAR-T Cells Simultaneously Targeting Tumor and Metastases Produce Highly Effective Control in Preclinical Models of Melanoma and Triple-Negative Breast CancerDustin A Cobb, Philip Mollica, Lixia Liu, et al.
Cancer Immunology Research|August 20, 2021
Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer PatientsAmanda M Lulu, Kara L Cummings, Erin D Jeffery, et al.
Pageof 1